Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Operating Margin: 2009-2024

Historic Operating Margin for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to 26.50%.

  • Ironwood Pharmaceuticals' Operating Margin rose 3385.00% to 61.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.34%, marking a year-over-year increase of 1012.00%. This contributed to the annual value of 26.50% for FY2024, which is 24004.00% up from last year.
  • Ironwood Pharmaceuticals' Operating Margin amounted to 26.50% in FY2024, which was up 112.41% from -213.54% recorded in FY2023.
  • Ironwood Pharmaceuticals' 5-year Operating Margin high stood at 60.97% for FY2022, and its period low was -213.54% during FY2023.
  • Its 3-year average for Operating Margin is -42.02%, with a median of 26.50% in 2024.
  • In the last 5 years, Ironwood Pharmaceuticals' Operating Margin slumped by 27,451bps in 2023 and then spiked by 24,004bps in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Operating Margin (Yearly) stood at 36.70% in 2020, then surged by 1,944bps to 56.13% in 2021, then soared by 483bps to 60.97% in 2022, then slumped by 27,451bps to -213.54% in 2023, then surged by 24,004bps to 26.50% in 2024.